Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice

Background/aimsSome studies showed that probiotics could improve the composition and structure of gut microbiota. Changes in the gut microbiota may alter bile acid (BAs) composition and kinetics, improving non-alcoholic fatty liver disease (NAFLD). However, it still needs to be clarified how probiot...

Full description

Bibliographic Details
Published in:	Frontiers in Nutrition
Main Authors:	Minghua Yang, Haoyang Wang, Ihtisham Bukhari, Ye Zhao, Huang Huang, Yong Yu, Xiangdong Sun, Yang Mi, Lu Mei, Pengyuan Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Subjects:	NAFLD FXR gut microbiota probiotics bile acids
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2023.1121203/full

Similar Items

Isorhamnetin in Quinoa Whole-Grain Flavonoids Intervenes in Non-Alcoholic Fatty Liver Disease by Modulating Bile Acid Metabolism through Regulation of FXR Expression
by: Xiaoqin La, et al.
Published: (2024-09-01)

Ginsenoside Rh4 Improves Hepatic Lipid Metabolism and Inflammation in a Model of NAFLD by Targeting the Gut Liver Axis and Modulating the FXR Signaling Pathway
by: Siming Yang, et al.
Published: (2023-06-01)

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains
by: Xin Ye, et al.
Published: (2022-10-01)

Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice
by: Shizhang Wei, et al.
Published: (2023-05-01)

Betaine promotes chicken growth through modulating gut microbiota and FXR-mediated activation of IGF genes
by: Yan Wang, et al.
Published: (2025-09-01)

Small intestinal taurochenodeoxycholic acid-FXR axis alters local nutrient-sensing glucoregulatory pathways in rats
by: T.M. Zaved Waise, et al.
Published: (2021-02-01)

Bile acids affect intestinal barrier function through FXR and TGR5
by: Guangyao Song, et al.
Published: (2025-07-01)

Commentary: Can FXR serve as a potential target for COVID-19 prevention?
by: Juan Pang, et al.
Published: (2023-04-01)

Dietary bile acid supplementation improves the intestinal health and growth performance of piglets partially through the FXR/AQPs pathway
by: Beibei Zhang, et al.
Published: (2025-05-01)

Triclosan exposure causes abnormal bile acid metabolism through IL-1β-NF-κB-Fxr signaling pathway
by: Jing Liu, et al.
Published: (2024-10-01)

Dietary bile acids improve breast muscle growth in chickens through FXR/IGF2 pathway
by: Liang Chen, et al.
Published: (2024-02-01)

Reply to correspondence 2 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
by: Nahee Hwang, et al.
Published: (2025-04-01)

Dietary Resistant Starch Regulates Bile Acid Metabolism by Modulating the FXR/LRH-1 Signaling Pathway in Broilers
by: Zhenxin Wang, et al.
Published: (2023-11-01)

Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
by: Yixuan Qiu, et al.
Published: (2021-01-01)

Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics
by: Huan Yang, et al.
Published: (2023-10-01)

Farnesoid X Receptor (FXR) Agonists and Protein Kinase Regulation in NAFLD and NASH: Mechanisms and Therapeutic Potential
by: Ayan Saha, et al.
Published: (2025-07-01)

Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions
by: Meilin Wei, et al.
Published: (2024-06-01)

Gypensapogenin A-Liposomes Efficiently Ameliorates Hepatocellular Lipid Accumulation via Activation of FXR Receptor
by: Yidan Deng, et al.
Published: (2024-08-01)

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis
by: Claudia D. Fuchs, et al.
Published: (2023-11-01)

HuangQi ChiFeng decoction maintains gut microbiota and bile acid homeostasis through FXR signaling to improve atherosclerosis
by: Jiaqi Fu, et al.
Published: (2023-11-01)

Bile Acid Physiology
by: Agostino Di Ciaula, et al.
Published: (2017-11-01)

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
by: Chuangzhen Lin, et al.
Published: (2022-05-01)

Suppressing FXR promotes antiviral effects of bile acids via enhancing the interferon transcription
by: Xue Liang, et al.
Published: (2024-08-01)

Weissella cibaria suppresses colitis-associated colorectal cancer by modulating the gut microbiota-bile acid-FXR axis
by: Qiuyao Hao, et al.
Published: (2025-07-01)

Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress
by: Weijia Cai, et al.
Published: (2023-11-01)

Tailoring FXR Modulators for Intestinal Specificity: Recent Progress and Insights
by: Amanda Morrison, et al.
Published: (2024-04-01)

Arisaema cum Bile Mitigate Febrile Seizure in Rats via Inhibition of Neuroinflammation, Regulation of FXR and GABA Signaling Pathway
by: Wu X, et al.
Published: (2025-06-01)

Pulsatilla decoction alleviates DSS-induced UC by activating FXR-ASBT pathways to ameliorate disordered bile acids homeostasis
by: Ying Xiao, et al.
Published: (2024-06-01)

Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway
by: Zhenhui Chen, et al.
Published: (2024-12-01)

Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5
by: Samuel A. J. Trammell, et al.
Published: (2020-05-01)

Yinchenhao Decoction Mitigates Cholestatic Liver Injury in Mice via Gut Microbiota Regulation and Activation of FXR-FGF15 Pathway
by: Weiwei Li, et al.
Published: (2025-06-01)

Emodin alleviates cholestatic liver injury by modulating Sirt1/Fxr signaling pathways
by: Zhi Hu, et al.
Published: (2024-07-01)

Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway
by: Xinqi Chen, et al.
Published: (2024-11-01)

Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia
by: Hongtao Xu, et al.
Published: (2023-11-01)

Intratracheal exposure to polyhexamethylene guanidine phosphate disrupts coordinate regulation of FXR-SHP-mediated cholesterol and bile acid homeostasis in mouse liver
by: You-Jin Choi, et al.
Published: (2022-12-01)

Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity
by: Julia Münzker, et al.
Published: (2022-06-01)

The Spatial‐Temporal Alternative Splicing Profile Reveals the Functional Diversity of FXR1 Isoforms in Myogenesis
by: Wei Wang, et al.
Published: (2024-12-01)

SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
by: Shuang Cui, et al.
Published: (2023-02-01)

Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice
by: Jinjing Chen, et al.
Published: (2024-04-01)

Comparative Behavioral Phenotypes of Fmr1 KO, Fxr2 Het, and Fmr1 KO/Fxr2 Het Mice
by: Rachel Michelle Saré, et al.
Published: (2019-01-01)